Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Mogamulizumab by Kyowa Kirin for Peripheral T-Cell Lymphomas (PTCL): Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Peripheral T-Cell Lymphomas (PTCL). According to...
Mogamulizumab by Kyowa Kirin for Oral Cancer: Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Oral Cancer. According to GlobalData, Phase...
Mogamulizumab by Kyowa Kirin for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Mogamulizumab is under clinical development by Kyowa Kirin and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction. According...